|
|
 |
|
Viewing report
|
|
|
|
Isis Pharmaceuticals, Inc. (ISIS) - Financial and Strategic SWOT Analysis Review
GlobalData, Sep 2011, Pages: 45
Isis Pharmaceuticals, Inc. (ISIS) - Financial and Strategic SWOT Analysis Review
Summary
Isis Pharmaceuticals, Inc. (Isis) is a pharmaceutical company specialized in antisense technology. The company engages in the discovery and development of new class antisense drugs that address significant unmet medical needs. Antisense technology is a direct route from genomics to drugs. The product pipeline of the company focuses on various therapeutic areas, namely, Cardiovascular, Cancer, Metabolic, Neurodegenerative, Inflammatory and Other diseases. Isis is headquartered in Carlsbad, California, the US.
Recently, the company formed a collaboration with Xenon Pharmaceuticals Inc., to discover and develop antisense drugs as novel treatments for the common disease anemia of inflammation (AI). Further, the company announced adding of two new drugs to its development pipeline, namely, ISIS-FGFR4Rx and ISIS-STAT3Rx.
Isis Pharmaceuticals, Inc. Key Recent Developments
Aug 11, 2011 Isis And CHDI Foundation Renew Drug Development Collaboration For Huntington's Disease
Aug 04, 2011 Isis Pharmaceuticals Reports Total Revenue Of $24.8m For Q2 2011
May 05, 2011 Isis Pharmaceuticals Reports Net Loss Of $20m For Q1 2011
Mar 16, 2011 Pharmaron To Supply Nucleoside Phosphoramidites To Isis Pharmaceuticals
Feb 28, 2011 Isis Reports Net Loss Of $14m For Q4 2010
This comprehensive SWOT profile of Isis Pharmaceuticals, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Isis Pharmaceuticals, Inc.
Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review
Isis Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011
AVI BioPharma Inc. (AVII) - Financial and Strategic SWOT Analysis Review
Isis Pharmaceuticals, Inc. - SWOT Analysis
Isis Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010
MAP Pharmaceuticals, Inc. (MAPP) - Financial and Strategic SWOT Analysis Review
Lexicon Pharmaceuticals, Inc. (LXRX) - Financial and Strategic SWOT Analysis Review
Infinity Pharmaceuticals, Inc. (INFI) - Financial and Strategic SWOT Analysis Review
ACADIA Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review
|
|
|
|
